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Introduction
The regulator of G protein signaling (RGS) and RGS-like pro-
teins comprise a family of at least 30 members that have been 
grouped into five subfamilies based on their structural and se-
quence homologies (Ross and Wilkie, 2000). RGS proteins pos-
sess a conserved 120–amino acid RGS domain that promotes 
their association with heterotrimeric G protein  subunits and 
confers their function as GTPase-accelerating proteins (GAPs). 
RGS2 belongs to the B/R4 subfamily of RGS proteins that are 
characterized by relatively simple structures wherein an RGS 
domain is flanked by short amino and carboxyl termini. Although 
RGS2 does not appear to contain any of the other established 
protein-interacting domains (e.g., PSD-95/Dlg/zona occludens-1, 
ras binding domain, and GoLoco) that have been identified 
within some RGS protein subfamilies, accumulating evidence 
supports the hypothesis that RGS2 may regulate cellular activity 
in a manner that is distinct from its known RGS domain function 
(Sinnarajah et al., 2001; Salim et al., 2003; Roy et al., 2006a; 
Schoeber et al., 2006). For example, it has recently been shown 
that RGS2 interacts with the TRPV6 member of the transient 
receptor potential family of cation channels to disrupt both Na
+ 
and Ca
2+ currents (Schoeber et al., 2006). This effect was depen-
dent on a stretch of amino acids (1–82) situated outside of the 
RGS domain, as it was not observed with an amino-terminal trun-
cation mutant. RGS2 also binds to tubulin to enhance microtubule 
polymerization, and this effect is dependent on a stretch of 
20 amino acids located outside of its RGS domain (Heo et al., 
2006). These studies support additional functions for RGS2 
other than its role as a GAP for Gq (Ingi et al., 1998; Bernstein 
et al., 2004) and regulator of Gs-mediated adenylyl cyclase 
activation (Roy et al., 2006a). In this study, we present evidence 
for a novel and unexpected function wherein RGS2 inhibits the 
translation of mRNA into protein by blocking the activity of the 
rate-controlling eIF2B.
Dysregulation of the protein synthesis machinery can con-
tribute to human disease states such as cancer, diabetes, cardiac 
hypertrophy, and neurodegeneration (Proud, 2007). The stages 
of mRNA translation are initiation, elongation, and termination. 
In eukaryotes, cellular control of initiation is governed by a fam-
ily of proteins referred to as eIFs (eukaryotic initiation factors; 
Proud, 2005). The rate-limiting step in translation occurs during 
initiation and is regulated by the heterotrimeric () GTPase 
eIF2 (Kimball, 1999). In its activated conformation, eIF2-GTP 
can form a ternary complex with Met-tRNAi, which then binds 
to the 40S ribosomal subunit to initiate protein synthesis. The 
guanine nucleotide–bound state of eIF2 is itself governed by the 
heteropentameric () guanine nucleotide exchange factor 
(GEF), eIF2B, and the eIF2-specific GAP, eIF5. One of the 
mechanisms to regulate eIF2 activity is phosphorylation of its 
T
he regulator of G protein signaling (RGS) proteins 
are a family of guanosine triphosphatase (GTPase)–
accelerating proteins. We have discovered a novel 
function for RGS2 in the control of protein synthesis. RGS2 
was found to bind to eIF2B (eukaryotic initiation factor 
2B  subunit) and inhibit the translation of messenger 
RNA (mRNA) into new protein. This effect was not observed 
for other RGS proteins tested. This novel function of RGS2 
is distinct from its ability to regulate G protein–mediated 
signals and maps to a stretch of 37 amino acid residues 
within its conserved RGS domain. Moreover, RGS2 was 
capable of interfering with the eIF2–eIF2B GTPase cycle, 
which is a requisite step for the initiation of mRNA transla-
tion. Collectively, this study has identified a novel role for 
RGS2 in the control of protein synthesis that is indepen-
dent of its established RGS domain function.
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(4 of 21 total positives). In contrast, RGS4 was not observed to 
interact with eIF2B when screened against the same mouse 
brain cDNA library. The 45–amino acid sequence identified in the 
RGS2 screen matches perfectly with amino acid residues 550–594 
of mouse eIF2B (equivalent to 554–598 in human). Notably, 
this corresponds to the highly conserved catalytic surface of 
eIF2B that enables the heteropentameric eIF2B complex to 
promote GDP dissociation from eIF2 (Boesen et al., 2004; 
Mohammad-Qureshi et al., 2007). It follows that if RGS2 were to 
bind to this region of eIF2B, it could alter the ability of eIF2B 
to promote protein synthesis. We first sought to confirm whether 
the interaction between RGS2 and eIF2B could occur at the 
protein level. We mixed purified RGS2 or RGS4 with lysates 
from Sf9 cells overexpressing eIF2B and examined whether 
there was an association between the proteins. Consistent with 
the results of the yeast two-hybrid screen, RGS2 interacted with 
eIF2B whether it was expressed as a monomer or as part of the 
pentameric eIF2B complex (i.e., ± eIF2B/eIF2B/eIF2B/
eIF2B; Fig. 1 A). Thus, it appears that the presence of the other 
four subunits does not sterically hinder the ability of eIF2B to 
associate with RGS2. In contrast, RGS4 did not specifically as-
sociate with either the eIF2B pentamer or monomeric eIF2B 
(Fig. 1 A). Next, we investigated whether there was an asso-
ciation between endogenously expressed RGS2 and eIF2B; 
 subunit in response to various cellular stressors. This is mediated 
by four stress-activated kinases: haem-regulated inhibitor, gen-
eral control nonderepressible-2, protein kinase activated by 
double-stranded RNA, and pancreatic endoplasmic reticulum 
eIF2 kinase (Dever, 2002; Ron, 2002). Phosphorylation of this 
highly conserved serine acts to decrease the dissociation rate of 
eIF2 from eIF2B, which essentially converts eIF2 from a substrate 
into a competitive inhibitor of eIF2B GEF activity. However, the 
control of protein synthesis in response to stress is multifaceted 
and cannot be solely explained by phosphorylation events.
Using a yeast two-hybrid screen, we have identified an 
interaction between RGS2 and eIF2B. This association between 
RGS2 and eIF2B was also observed between the endogenous 
proteins in cells. RGS2 was capable of inhibiting de novo pro-
tein synthesis in a manner independent of its RGS domain func-
tion. Collectively, this work has identified and characterized 
RGS2 as a novel component in the control of protein synthesis.
Results
Physical interaction between RGS2  
and eIF2B
Initial experiments using full-length human RGS2 as bait in a 
yeast two-hybrid screen pointed to an interaction with eIF2B 
Figure 1.   In vitro interaction between RGS2 
and eIF2B. (A) Flag-tagged eIF2B was ex-
pressed  in  Sf9  cells  in  either  its  monomeric 
form or as part of the eIF2B holoprotein (i.e., 
±  eIF2B/eIF2B/eIF2B/eIF2B).  The  pre-
cleared cell lysate was obtained as described 
in Materials and methods, and the indicated 
RGS protein was added to these lysates to a 
final  concentration  of  500  nM.  The  mixture 
was  immunoprecipitated  with  anti-Flag  anti-
body, and samples were run on SDS-PAGE 
and transferred. Membranes were probed with   
antihistidine antibody to identify coimmuno-
precipitated RGS proteins (top) or anti-eIF2B 
to view immunoprecipitated eIF2B (bottom) 
from lysate. The blots shown are representative 
of  at  least  three  independent  experiments.   
(B) Coimmunoprecipitation of endogenous RGS2 
with endogenous eIF2B. UMR-106 osteoblast-
like osteosarcoma cells were treated for 3 h 
with 100 µM forskolin to induce RGS2 expres-
sion. Vehicle control and forskolin-treated cell 
lysates  (1  mg  total  protein)  were  incubated 
with protein A/G agarose beads either without 
(lanes 1 and 3) or with (lanes 2 and 4) anti-
eIF2B antibody, or else were added directly 
to the gel (100 µg total protein; lanes 5 and 6). 
Protein A/G agarose beads were extensively 
washed, and the bound protein was removed 
by heating and added to the gels (lane 1–4). 
The  SDS-PAGE  gel  was  transferred  to  PVDF 
membrane and probed using anti-RGS2 anti-
body (top) and stripped and reprobed using 
the same eIF2B antibody used for immuno-
precipitation  (IP;  bottom).  The  results  shown 
are typical of three independent experiments. 
Asterisks  denote  nonspecific  immunoreactive 
bands. IB, immunoblot. Molecular mass indi-
cators are expressed in kilodaltons.757 RGS2 BINDS TO eIF2B AND INHIBITS PROTEIN SYNTHESIS • Nguyen et al.
of RGS2 on the GEF activity of eIF2B by measuring the poten-
tial of eIF2B to promote the dissociation of [
3H]GDP from eIF2. 
As illustrated, all three of the RGS2 proteins examined were 
able to dose-dependently inhibit eIF2B GEF activity for eIF2 
(Fig. 3 D). Collectively, these data show that RGS2 can inter-
fere with eIF2B GEF activity in a manner independent of its 
established G protein effects.
Identification of the RGS2 domain involved 
in regulating protein synthesis
The observation that RGS2 can interfere with the eIF2–eIF2B 
GTP cycle suggests that RGS2 may bind to eIF2B in a manner 
similar to that of eIF2. We identified a stretch of 37 amino acid 
residues within the RGS2 protein sequence (79–115) that shared 
35% homology (nine identical and four conserved) with the 
eIF2B-binding domain of eIF2 (200–333; Fig. 4 A; Kimball 
et al., 1998). This corresponding sequence within other RGS 
and RGS-like proteins did not exhibit the same degree of 
identity. Structural analyses revealed that the homologous re-
gions of human RGS2 (Protein Data Bank accession no. 2af0; 
therefore, we addressed whether the interaction could occur 
between the native proteins in UMR-106 osteoblast-like cells. 
For these experiments, we were required to up-regulate endoge-
nous RGS2 expression by way of the diterpene forskolin, given 
that native RGS2 in osteoblast cultures is undetectable by 
immunoblot analysis under basal conditions (Roy et al., 2006b). 
Endogenous eIF2B was immunoprecipitated from whole cell 
lysates, and the immune complex was examined for RGS2 
immunoreactivity. Indeed, endogenously expressed RGS2 was 
observed to coimmunoprecipitate with eIF2B (Fig. 1 B). RGS2 
expression in forskolin-treated cells and from the coimmuno-
precipitation assay presented as a doublet band, which is con-
sistent with a recent report that RGS2 can have multiple protein 
products resulting from alternative translation initiation sites 
(Gu et al., 2008). This observed association between RGS2 and 
eIF2B in lysates from nontransfected cells shows that the inter-
action between the two proteins is genuine and thus implies a 
possible role for endogenous RGS2 in mRNA translation.
Inhibition of protein synthesis by RGS2
The role of eIF2B in the control of protein synthesis is to pro-
mote guanine nucleotide exchange on the eIF2 subunit. Protein 
translation cannot be initiated in the absence of a functional 
eIF2–eIF2B relationship. Thus, we hypothesized that the inter-
action between RGS2 and eIF2B may act to interfere with de 
novo protein synthesis. Therefore, we monitored the production 
of the luminescent protein, Coleoptera luciferase, from its mRNA 
using a rabbit reticulocyte lysate-based in vitro translation assay. 
Addition of RGS2 resulted in a significant decrease in protein 
synthesis compared with control (Fig. 2 A). In contrast, neither 
RGS1 (despite its reported interaction with eIF3; see Discus-
sion) nor RGS4 had any effect on protein synthesis (Fig. 2 A). Each 
of the three purified RGS proteins was functional with respect to 
its known GAP activity, as all were able to dose-dependently in-
crease the rate of M1 muscarinic receptor–stimulated G11 GTP 
hydrolysis to approximately the same extent (Fig. 2 B).
RGS2 regulation of protein synthesis and 
the RGS domain
To better define the mechanism by which RGS2 controls protein 
synthesis, we examined the role of its RGS domain. We generated 
two mutations within this region of RGS2 that would act to 
decrease or eliminate its GTPase-accelerating function: RGS2-
N149A and RGS2-C169 (Fig. 3 A). The N149A point mutation 
is thought to disrupt a critical contact point between RGS2 and 
G protein  subunits, whereas C169 removes a substantial por-
tion of the RGS domain at its carboxyl terminus. As expected, nei-
ther of these RGS2 mutants was able to increase agonist-stimulated 
GTP hydrolysis above that of agonist alone (Fig. 3 B). In contrast, 
when the two RGS2 mutants were used in the in vitro translation 
assay, both proteins retained the ability to inhibit the translation 
of luciferase mRNA into protein to the same degree as that of 
wild-type RGS2 (Fig. 3 C). These results imply that the ability 
of RGS2 to inhibit protein synthesis is independent of its effects 
on G proteins.
We hypothesized that the binding of RGS2 to eIF2B might 
disrupt the eIF2–eIF2B GTP cycle. Thus, we examined the effects 
Figure 2.  Inhibition of protein synthesis by RGS2. (A) The effects of 4 µM 
purified RGS proteins on the synthesis of the reference luciferase protein 
were examined in a reticulocyte-based in vitro translation assay as de-
scribed in Materials and methods. (B) Concentration response effects of 
full-length RGS proteins on steady-state, agonist-stimulated GTPase activity 
of M1 muscarinic receptor–activated G11 as described in Materials and 
methods. The data are presented as mean ± SEM of three independent 
experiments performed in triplicate. *, P < 0.05 versus control (one-sample 
t test).JCB • VOLUME 186 • NUMBER 5 • 2009   758
protein synthesis (Fig. 4 B) and correspondingly failed to inter-
act with monomeric eIF2B (Fig. 4 D). Additional experiments 
assessed the effect of a purified RGS2 peptide corresponding 
to residues 79–116 on translation. The results revealed that 
the RGS2 peptide was capable of inhibiting the translation of 
luciferase  mRNA  into  protein  in  a  concentration-dependent 
manner (Fig. 4 C). Collectively, these data demonstrate that RGS2 
amino acids 79–116 are both sufficient and necessary to inhibit 
protein synthesis.
We went on to generate two additional RGS2 mutants 
termed RGS2-ala1 and RGS2-ala2 in an attempt to further char-
acterize this new domain of RGS2 that is involved in protein 
translation (Fig. 5 A). The RGS2-ala mutants each contain a 
series of alanine substitutions at strategic locations between 
residues 79 and 116. For RGS2-ala1, the substitutions are based 
on the charge and position of the native residue within the 
helix–linker–helix structure of wild-type RGS2, whereas the sub-
stitutions in RGS2-ala2 correspond to the conserved residues 
between the homologous segments of eIF2 and RGS2 (Fig. 4 A). 
RGS2-ala1 and RGS2-ala2 were examined for their potential 
to interact with eIF2B and regulate de novo protein synthesis. 
In comparison with wild-type protein, RGS2-ala2 had minimal 
interactions with monomeric eIF2B and, accordingly, did not 
Soundararajan et al., 2008) and bacterial aIF2 (Protein Data 
Bank accession no. 1nee; Gutiérrez et al., 2004) were each com-
prised of two  helices oriented at a 45° angle and connected by 
a short linker. We used this homologous sequence of 37 amino 
acids as a point of reference to generate N79-RGS2, RGS2-
C116, and RGS2-79–116 (Fig. 3 A) in an attempt to identify 
the active domains within RGS2 that confer its novel function. 
Deletion of the RGS2 amino terminus did not interfere with 
RGS2 GAP activity. As reported previously (Bernstein et al., 
2004), both wild-type RGS2 and N79-RGS2 were able to pro-
mote  agonist-stimulated  G11  GTP  hydrolysis  (unpublished 
data). This is consistent with the fact that truncation of RGS2 
upstream of residue 79 leaves the RGS box intact. However, 
RGS2-C116 and RGS2-79–116 were without RGS2 GAP 
activity (unpublished data). This was expected given that these 
mutations disrupt the integrity of the RGS domain. The three 
RGS2 deletion mutants were used in the translation assay to 
examine their effects on protein synthesis. Truncation of RGS2 
either upstream or downstream of the homologous 37–amino 
acid sequence did not disrupt the ability of RGS2 to impair pro-
tein synthesis. RGS2-C116 and N79-RGS2 each inhibited 
mRNA translation to a comparable level as that of wild-type 
RGS2 (Fig. 4 B). In contrast, RGS2-79–116 had no effect on 
Figure  3.  RGS2-mediated inhibition of pro-
tein synthesis is independent of its RGS domain 
function. (A) Schematic of the purified RGS2 
proteins used throughout the study. (B and C) 
The effects of full-length RGS2, RGS2-N149A, 
and RGS2-C169 (4 µM) were examined on 
steady-state, agonist-stimulated GTPase activ-
ity of M1 muscarinic receptor–activated G11 
(B) or synthesis of the reference luciferase pro-
tein in a reticulocyte-based in vitro translation 
assay (C) as described in Materials and meth-
ods. The data are presented as mean ± SEM 
of three independent experiments performed 
in triplicate. *, P < 0.05 versus control (one-
sample t test). (D) The ability of 150 nM puri-
fied eIF2B to promote dissociation of [
3H]GDP 
from purified eIF2 was examined as described 
in Materials and methods. This activity was as-
sessed in the absence and presence of three 
concentrations  of  RGS2,  RGS2N149A,  and 
RGS2C169.  The  data  are  presented  as 
mean ± SEM of four independent experiments 
performed in duplicate.759 RGS2 BINDS TO eIF2B AND INHIBITS PROTEIN SYNTHESIS • Nguyen et al.
and suggest that the common residues between eIF2 and RGS2 
may contribute to eIF2B binding.
RGS2 residues 79–116 inhibit protein 
synthesis in cells
We next assessed whether RGS2 and its putative eIF2B- 
interacting domain had any impact on protein synthesis in cells. 
We used two cellular models for these experiments, H9c2 and 
MCF-7 cells, and infected them with adenovirus coding for full-
length RGS2 and an RGS2 minigene comprising residues 79–116. 
In both of the cell lines tested, RGS2 and the RGS2 minigene 
were able to attenuate de novo protein synthesis to comparable 
levels (Fig. 6). The magnitude of inhibition was not as robust as 
that observed in the in vitro translation assay, but this was not 
surprising given the complexity of the protein synthesis machin-
ery in a whole cell context.
One possible contributing factor to the observed RGS2 
effect on cellular protein synthesis may be that viral infection 
could promote phosphorylation of serine 51 on eIF2, which it-
self may impede global protein synthesis. To address this issue, 
we made use of a previously described mouse embryonic fibro-
blast (MEF) cell line in which the gene for eIF2 was targeted 
to mutate the serine 51 phosphorylation site to a nonphosphory-
latable alanine residue (Scheuner et al., 2001). Control MEF cells 
(eIF2
S/S) and mutant MEF cells (eIF2
A/A) were used to measure 
de novo protein synthesis after infection with RGS2 and the 
RGS2 minigene (Fig. 7). Consistent with our results using the 
H9c2 and MCF-7 cells, a decrease in protein synthesis was also 
observed in both of these MEF cell lines. The fact that the de-
crease in de novo protein synthesis was retained in the eIF2
A/A 
cells argues that the mechanism by which RGS2 inhibits trans-
lation is independent of serine 51 phosphorylation on eIF2. 
There were no differences observed in the cellular uptake of 
radiolabeled leucine between the various infection conditions 
(unpublished data). These data further reinforce the notion that 
RGS2 may serve a regulatory role in protein synthesis through 
its interactions with eIF2B.
Protein synthesis is elevated in the 
absence of endogenous RGS2
Lastly, we went on to investigate the effect of silencing RGS2 
expression on cellular protein synthesis. We isolated hepatocytes 
from wild-type and RGS2 knockout mice (RGS2
/) and com-
pared their levels of de novo protein synthesis. These experiments 
revealed a 60% increase in protein synthesis in RGS2
/ cells 
compared with wild-type controls (Fig. 8). These results are in 
line with previous observations that knocking out either general 
control nonderepressible-2 or haem-regulated inhibitor decreases 
eIF2 phosphorylation and results in elevated levels of protein 
synthesis (Han et al., 2001; Lu et al., 2001; Deng et al., 2002). We 
did not observe any difference in the rate of protein catabolism 
between  the  two  hepatocyte  cell  cultures  (unpublished  data). 
These results are consistent with the notion that in the absence of 
endogenous RGS2, there would be fewer restrictions on the trans-
lational machinery and, therefore, elevated levels of protein syn-
thesis. Collectively, this study provides strong evidence that RGS2 
plays a pivotal role in regulating the protein synthesis machinery.
have a significant impact on the translation of luciferase mRNA 
(Fig. 5). In contrast, RGS2-ala1 retained binding to eIF2B and 
also significantly decreased protein translation (Fig. 5). These 
results further reinforce the proposal that this segment of RGS2 
is involved in binding eIF2B in the regulation of protein synthesis 
Figure 4.  RGS2-mediated inhibition of protein synthesis and binding to 
eIF2B is dependent on amino acids 79–116. (A) Comparison between the 
putative eIF2B-interacting domain of RGS2 and the established eIF2B- 
interacting domain of eIF2. Identical residues are denoted by yellow 
shading, whereas conserved substitutions are indicated in green. (B) The 
effect of full-length RGS2, N79-RGS2, RGS2-C116, and RGS2-79–116 
(4 µM) was examined on luciferase protein synthesis in a reticulocyte-
based in vitro translation assay as described in Materials and methods. 
The data are presented as mean ± SEM of three independent experiments 
performed in triplicate. *, P < 0.05 versus control (one-sample t test). (C) The 
effect of RGS2, RGS4, or an RGS2 peptide corresponding to amino acid 
residues 79–116 on luciferase protein synthesis. The data are presented 
as mean ± SEM of three independent experiments performed in duplicate. 
(D) RGS2 and RGS2-79–116 were examined for interactions with mono-
meric eIF2B as described for Fig. 1. The blots are representative of three 
independent experiments. IB, immunoblot. Molecular mass indicators are 
expressed in kilodaltons.JCB • VOLUME 186 • NUMBER 5 • 2009   760
L79, E86, L87, and I110. This suggests that these residues are 
responsible for the observed difference in eIF2B binding 
between RGS2-ala2 and RGS2-ala1; the residual interactive 
forces for binding eIF2B would presumably be made up of the 
remaining five overlapping substitutions, although this cannot 
be conclusively stated at this point in time. The successful   
crystallization of an RGS2–eIF2B complex (or parts thereof) 
will provide more information on the molecular determinants 
for this interaction.
Several potential links between G protein–mediated signal-
ing networks and cellular control of protein synthesis have pre-
viously been noted, although no direct effects on the initiation 
of mRNA translation have been established. The  subunit of 
eIF2B has been reported to interact with the carboxyl tails of the 
2A, 2B, 2C, and 2 adrenergic receptors in a yeast two-
hybrid screen, but not to the carboxyl tail of the vasopressin re-
ceptor (Klein et al., 1997). Similarly, eIF2B has been shown to 
interact with the third intracellular loop of the 2B and 2C 
adrenergic receptors in a manner that may be dependent on 14–3-3 
(Prezeau et al., 1999). The third intracellular loop of the M4 
muscarinic receptor, but not M1 or M2, was also reported to asso-
ciate with eukaryotic elongation factor 1A2 to promote guanine 
Discussion
These results outline a novel function for RGS2 in the control 
of protein synthesis in addition to its established role as a GAP 
for heterotrimeric G proteins. RGS2 is able to bind to the  sub-
unit of the GEF, eIF2B, and this interaction appears to interfere 
with the initiation of mRNA translation by preventing guanine 
nucleotide exchange on eIF2. The notable similarities in pro-
tein sequence and tertiary structure between the homologous 
regions of RGS2 and eIF2 led to the hypothesis that RGS2 
residues 79–116 play a role in binding eIF2B. Mutagenesis 
analyses confirmed that this segment of RGS2 is required for its 
interaction with eIF2B and regulation of translation. Further-
more, using an alanine substitution approach, we were able to   
identify key residues involved in the protein–protein inter-
action. The near complete loss of eIF2B binding and inhibition 
of in vitro translation by RGS2-ala2 suggests the nine substi-
tuted residues within this mutant protein are critical contact points 
for RGS2–eIF2B interactions. This is consistent with the fact 
that these nine residues are identical between the homologous 
segments of RGS2 and eIF2. It is noteworthy to point out the 
four amino acid substitutions that are unique to RGS2-ala2: 
Figure  5.  RGS2  residues  involved  in  bind-
ing  eIF2B  and  regulating  protein  synthesis.  
(A)  Identity  and  location  of  RGS2  amino   
acids targeted for alanine substitution (yellow 
shading). (B) The effect of RGS2, RGS2-ala1, 
and RGS2-ala2 on luciferase protein synthesis 
as described in Materials and methods. The 
data are presented as mean ± SEM of three 
independent experiments performed in dupli-
cate. *, P < 0.05 versus control (one-sample 
t  test).  (C)  Interactions  between  monomeric 
eIF2B and wild-type RGS2, RGS2-ala1, and 
RGS2-ala2.  The  blots  are  representative  of 
two independent experiments. IB, immunoblot. 
Molecular  mass  indicators  are  expressed  in 
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which depends upon both the activity and the availability of 
the exchange factor eIF2B. The best characterized inhibitory 
mechanism involves the phosphorylation of Ser51 on the eIF2 
subunit (Gebauer and Hentze, 2004). Other mechanisms for 
inhibiting mRNA translation by way of eIF2B have also been 
reported. For example, GSK3 directly phosphorylates eIF2B 
at serine 540 in intact cells, and this inhibits eIF2B GEF activity 
by up to 80% (Welsh et al., 1998). In addition, it has been shown 
that the effects of eIF2B on eIF2 can be decreased by the bind-
ing of the latter to eIF5. The primary function of eIF5 is to pro-
mote GTP hydrolysis by eIF2; however, when present at elevated 
levels, eIF5 may act to sequester eIF2 from eIF2B, thereby im-
peding protein synthesis (Singh et al., 2006). These results sug-
gest a comparable inhibitory mechanism wherein the interaction 
between eIF2 and eIF2B similarly is hindered by the binding of 
a third protein, in this case the association of RGS2 with eIF2B. 
Although the specific protein target differs, the functional con-
sequence in both cases is an attenuation of guanine nucleotide 
exchange on eIF2.
nucleotide exchange on the latter (McClatchy et al., 2002), which 
was suggested to be a mechanism of regulating M4 muscarinic 
receptor recycling (McClatchy et al., 2006). No effects of RGS 
proteins on mRNA translation have been reported until now, 
although RGS1 was identified as a binding partner for eIF3 
in a yeast two-hybrid screen (http://www.signaling-gateway.org/
data/Y2H/cgi-bin/y2h_int.cgi?id=17628). The latter interaction 
was not confirmed at the protein level, and our study has not 
shown RGS1 to have any effect on protein synthesis. Nonethe-
less, these data support a role for G protein–mediated signaling 
networks in the control of protein synthesis.
Under conditions of cellular stress such as oxidative dam-
age, nutrient deprivation, viruses, and heat shock, the overall rate 
of mRNA translation into protein is reduced (although the syn-
thesis of stress-related proteins is maintained or increased through 
specialized alternative pathways; Ron, 2002; Wek et al., 2006). 
A variety of mechanisms exist to reduce global protein synthe-
sis, and for the most part, these involve changes in initiation. Of 
particular importance is the rate-limiting eIF2–eIF2B interaction, 
Figure 6.  RGS2 amino acids 79–116 are sufficient to inhibit cellular 
protein synthesis. (A and B) H9c2 cardiomyoblasts (A) and MCF-7 adeno-
carcinoma cells (B) were infected with adenovirus (MOI = 4) encoding 
GFP (control), RGS2, or an RGS2 minigene for 48 h and used in a 
[
3H]leucine protein synthesis assay as described in Materials and methods. 
The data were calculated as cpm/µg of total protein, normalized as a 
percentage of control, and are expressed as the mean ± SEM of five in-
dependent experiments performed in triplicate. *, P < 0.05 versus control 
(one-sample t test).
Figure  7.  RGS2-mediated  inhibition  of  cellular  protein  synthesis  is   
independent of eIF2 serine 51 phosphorylation. (A and B) MEF eIF2
S/S 
(A) and eIF2
A/A (B) cell lines were infected with adenovirus (MOI = 4) 
encoding RGS4 (control), RGS2, or an RGS2 minigene for 48 h and used 
in a [
3H]leucine protein synthesis assay as described in Materials and 
methods. The data were calculated as cpm/µg of total protein, normalized 
as a percentage of control, and are expressed as the mean ± SEM of three 
independent experiments performed in triplicate. *, P < 0.05 versus control 
(one-sample t test).JCB • VOLUME 186 • NUMBER 5 • 2009   762
One interesting aspect of RGS2 signaling is that RGS2 
mRNA and protein expression can be up-regulated in response 
to the same forms of cellular stress that inhibit protein synthe-
sis, including oxidative stress, heat shock, DNA damage, and 
mechanical stress (Siderovski et al., 1994; Zmijewski et al., 2001; 
Song and Jope, 2006; Santos de Araujo et al., 2007). For exam-
ple, treatment of 1321N1 astrocytoma cells with H2O2 leads to 
the up-regulation of RGS2 mRNA and protein in a concentration-
dependent manner, and subjecting these cells to heat shock also 
results in increased levels of RGS2 mRNA in a time-dependent 
manner (Zmijewski et al., 2001). Likewise, when SH-SY5Y cells 
were treated with the DNA-damaging agent camptothecin, RGS2 
mRNA levels were found to increase, whereas RGS4 mRNA 
levels decreased (Song and Jope, 2006). Although eIF2 phos-
phorylation and RGS2 up-regulation tend to be triggered by 
similar stimuli, these two processes are likely distinct and sepa-
rated on a temporal level. It is conceivable that changes in trans-
lation mediated by stress-activated kinases could be prolonged 
by RGS2 because the increase in its protein levels might be 
expected to coincide with the eventual dephosphorylation of 
serine 51 in eIF2. It still remains to be demonstrated whether 
endogenous RGS2 can attain sufficient protein levels in cells to 
replicate the effects observed on de novo protein synthesis after 
viral infection. This has been hindered primarily by the fact that 
the majority of agents and stressors that up-regulate endogenous 
RGS2 also induce eIF2 phosphorylation, thereby making it 
difficult to assign the contribution from each signaling event to-
ward controlling protein synthesis. However, the observation that 
levels of RGS2 required for maximal GAP activity (its estab-
lished biochemical function) closely mirror those needed in the 
in vitro translation assay suggest that endogenous levels of RGS2 
are sufficient to regulate translation in cells. Moreover, we have 
shown that endogenous RGS2 and eIF2B can be coimmuno-
precipitated. Other factors, such as the complex and changeable 
intracellular distribution patterns found with RGS2 and the po-
tential effects of posttranslational modifications, may also play 
a role. Our attempts to circumvent these obstacles by using the 
Figure  8.  Protein  synthesis  is  elevated  in  RGS2
/  mice.  Hepatocytes 
from wild-type control and RGS2
/ mice were prepared and used in a 
[
3H]leucine protein synthesis assay as described in Materials and methods. 
The data were calculated as cpm/µg of total protein, normalized as a 
percentage of control, and are expressed as the mean ± SEM of three in-
dependent experiments performed in triplicate. *, P < 0.05 versus control 
(paired t test).
RGS2
/ mice provide strong evidence that endogenous levels 
of RGS2 are sufficient to regulate translation; however, we 
cannot rule out the possibility that the observed difference in 
protein synthesis between wild-type and RGS2
/ cells is 
not the result of an indirect effect unrelated to RGS2 regulation 
of eIF2B.
Its up-regulation in response to stress suggests that RGS2 
may help to maintain cellular integrity. Indeed, RGS2 has previ-
ously been shown to act as a negative regulator of 1-adrenergic 
receptor–stimulated cardiomyocyte hypertrophy (Zou et al., 
2006). In primary cultures of ventricular myocytes, induction of 
hypertrophy by the 1-adrenergic receptor agonist phenylephrine 
resulted in the selective increase of RGS2 mRNA over RGS1, 
RGS3, RGS4, and RGS5 (Zou et al., 2006). Overexpression of 
RGS2 in these cells completely blocked the phenylephrine-
dependent increase in cell size as well as the induced expression 
of various genetic markers for cardiac hypertrophy (Zou et al., 
2006). These results are consistent with the report that down-
regulation of endogenous RGS2 by way of RNAi exacerbates car-
diomyocyte hypertrophy (Zhang et al., 2006). Such findings 
are typically thought to reflect the negative effects of RGS2 on 
Gq-mediated signaling; however, given that hypertrophy is char-
acterized by an increase in protein synthesis and cell size, one 
could argue based on these results that stress-induced up-regulation 
of RGS2 expression may impede the development of cardiac 
hypertrophy by inhibiting global protein synthesis. Indeed, de novo 
protein synthesis appears to be a requirement for cardiomyocyte 
hypertrophy to develop in some cell-based models (Hardt et al., 
2004; Shan et al., 2007).
In conclusion, the present study has identified RGS2 as a 
component of the protein synthesis machinery. This novel func-
tion of RGS2 may serve as an unexpected regulatory mechanism 
of the cellular stress response. Furthermore, the observation that 
a minigene coding for the RGS2 residues involved in binding 
eIF2B (79–116) is sufficient to inhibit de novo protein synthesis 
provides a template for the development of drugs to treat diseases 
that are characterized by impaired protein synthesis such as 
neoplasias, diabetes, cardiac hypertrophy, and neurodegeneration 
(Proud, 2007).
Materials and methods
Reagents and clones
Plasmids encoding histidine-tagged wild-type RGS2, RGS4, and N79-
RGS2 were provided by J. Hepler (Emory University, Atlanta, GA). The 
cDNA for RGS1 was provided by D. Siderovski (University of North Caro-
lina at Chapel Hill, Chapel Hill, NC) and subcloned into pET19b. The 
baculovirus coding for an M1 muscarinic receptor–G11 fusion protein was 
provided by T. Haga (University of Tokyo, Hongo, Japan). Baculoviruses 
encoding all five Flag-tagged subunits of eIF2B were generated as de-
scribed previously (Fabian et al., 1997). RGS2-N149A, RGS2-C116, 
and RGS2-C169 were made using the Quikchange site-directed muta-
genesis kit (Agilent Technologies). RGS2 79–116 was made by inverse 
PCR using phosphorothioate-modified primers (Stoynova et al., 2004). The 
purified RGS2 peptide was made by custom peptide synthesis, and the 
RGS2-ala mutants were made by custom gene synthesis (Genscript Corpo-
ration). Anti-eIF2B and protein A/G PLUS-agarose beads were purchased 
from Santa Cruz Biotechnology, Inc. Anti-RGS2 was purchased from 
Genway Biotech, Inc. Protein G–agarose beads were purchased from GE 
Healthcare. Anti-Flag M2 monoclonal antibody and other reagents were 
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washed by resuspension and centrifugation once with IB buffer and once 
with 0.1 M Tris-HCl, pH 8.0. The protein-refolding process was accomplished 
by extracting inclusion bodies with extraction buffer (10 mM Tris-HCl, 
pH 8.0, 0.5 mM EDTA, and 6 M guanidine hydrochloride) followed by 
dialysis against buffer A (50 mM Hepes, pH 7.5, 500 mM NaCl, 20 mM   
-mercaptoethanol, 10% glycerol, 0.5 mM PMSF, and 2 M urea) and buf-
fer B (50 mM Hepes, pH 7.5, 500 mM NaCl, 20 mM -mercaptoethanol, 
10% glycerol, 0.5 mM PMSF, and 500 mM urea). The refolded protein 
was purified by nickel chromatography followed by size-exclusion chroma-
tography as described in the previous paragraph for RGS1 and RGS4 ex-
cept that the concentration of NaCl was 0.5 M throughout the imidazole 
elution step and reduced to 0.3 M for the final gel filtration step. For RGS2-
ala1 and RGS2-ala2, the proteins were purified by nickel chromatography 
and dialyzed with storage buffer (50 mM Hepes, pH 7.5, 500 mM NaCl, 
20 mM -mercaptoethanol, 0.1 mM PMSF, 1 µg/ml aprotinin, 10 µg/ml 
leupeptin, and 0.5 mM urea) to remove imidazole. Protein samples were 
placed in aliquots and stored at 80°C.
GTP hydrolysis assay
Sf9 insect cells at a density of 2 × 10
6 cells/ml were infected with baculo-
viruses encoding G1, G2, and an M1 muscarinic receptor–G11 fusion 
protein. At 48 h after infection, cells were centrifuged at 228 g for 5 min, 
resuspended in PBS, and centrifuged again. The resulting pellet was resus-
pended in one third of the original volume of lysis buffer (20 mM Tris, pH 
8.0, 0.1 mM PMSF, 10 µg/ml leupeptin, and 1 µg/ml aprotinin) and incu-
bated on ice for 15 min. The cells were lysed using a homogenizer (Poly-
tron; Brinkmann Instruments) and centrifuged at 500 g for 10 min. The 
supernatant was retained and centrifuged for 30 min at 48,000 g. The 
supernatant from this centrifugation was discarded, and the pellets were 
resuspended in 0.01 vol of lysis buffer and stored at 80°C.
Membranes were assayed for carbachol-stimulated GTP hydrolysis 
for 5 min at 30°C in the absence and presence of the indicated RGS pro-
teins. The reaction buffer contained 10
6 cpm/assay -[
32P]GTP, 20 mM 
Hepes, pH 7.5, 1 mM EDTA, 1 mM DTT, 200 nM GTP, 0.5 mM ATP, 0.1 mM 
PMSF, 1 µg/ml aprotinin, 10 µg/ml leupeptin, 0.1 mM ascorbic acid, 
300 mM NaCl, and 2 mM MgCl2. Nonspecific GTPase activity was de-
fined as that in the presence of membranes plus the inverse agonist, 10 µM 
tropicamide, and these values were subtracted to yield the specific agonist- 
and receptor-dependent signal. GTP hydrolysis reactions were terminated 
by the addition of 5% Norit in 50 mM NaH2PO4, pH 3.0. The reaction 
mixture was centrifuged at 2,000 g, and 
32Pi was recovered from the 
supernatant. Radioactivity was measured on a liquid scintillation counter 
(Packard Tri-Carb 2900TR; PerkinElmer).
In vitro translation assay
Translation was measured as the synthesis of luciferase protein from lucifer-
ase mRNA using an in vitro translation kit (Applied Biosystems) according 
to the manufacturer’s protocol. In brief, rabbit reticulocyte lysates were 
combined with 20 µM amino acid mixture, 0.5 µg luciferase RNA (Pro-
mega), 1× low salt translation mix, and RGS proteins where indicated. The 
final concentration of NaCl in the assay was equalized to 300 mM by dilu-
tion. The mixture was incubated at 30°C for 45 min, and luminescence 
was detected with luciferase assay substrate (Promega) using a microplate 
reader (LMax II; MDS Analytical Technologies).
Cellular protein synthesis assay
Cells were seeded in 12-well cluster plates at a density of 500,000 cells/
well. 24 h later, cells were infected with the indicated virus. At 48 h after 
infection, the growth medium was removed and replaced with reduced-
serum medium (Opti-MEM I; Invitrogen) supplemented with 0.5 µCi/ml 
[
3H]leucine for 4 h. Cells were washed with PBS and incubated on ice with 
ice-cold lysis buffer (20 mM Hepes, pH 7.5, 50 mM KCl, 0.1 mM PMSF, 
1 µg/ml aprotinin, 10 µg/ml leupeptin, 0.1 mM EDTA, 10% [vol/vol] 
glycerol, and 1% Triton X-100) for 15 min. Protein concentrations were 
measured using a BSA protein assay (Bio-Rad Laboratories). An equal vol-
ume of the cell lysate was combined with a 25% (wt/vol) solution of tri-
chloroacetic acid to precipitate the protein, subjected to a vigorous vortex, 
and incubated on ice for 30 min. The mixture was filtered through a filtration 
apparatus (Millipore) onto glass microfiber disks (GF/C; GE Healthcare) 
and washed three times each with 5% TCA followed by 100% ethanol. 
Disks were air dried overnight, and their radioactivity was measured using 
a liquid scintillation counter (Packard Tri-Carb 2900TR; PerkinElmer).
eIF2B GEF Assay
The ability of eIF2B to promote the dissociation of GDP from eIF2 was 
measured as described previously (Kimball et al., 1991). In brief, eIF2 
Mouse hepatocyte isolation and culture
RGS2
/ mice were provided by J. Penninger (Institute of Molecular Bio-
technology, Vienna, Austria). Experiments involving RGS2
/ mice were 
approved by the Council on Animal Care at the University of Western On-
tario and adhered to the guidelines of the Canadian Council of Animal 
Care. Male mice (1–2-mo old) were anesthetized with ketamine/xylazine 
(100 mg/kg; 5 mg/kg), and livers were exposed and perfused through the 
vena cava with Ca
2+-free Hanks’ balanced solution at a rate of 5 ml/min 
for 10 min followed by serum-free Williams’ medium containing 50 U/ml 
collagenase (type II; Worthington Biochemical Corporation), 10 mM Hepes, 
and 0.004 N NaOH at a rate of 5 ml/min for 15 min. The livers were re-
moved  and  hepatocytes  separated  by  Percoll  gradient  separation  (GE 
Healthcare). Hepatocytes were cultured in Williams’ medium supplemented 
with 10% FBS for 24 h before analysis of de novo protein synthesis.
Cell culture
MEF eIF2 S/S and eIF2 A/A cells were provided by R. Kaufman (Univer-
sity of Michigan, Ann Arbor, MI) and maintained in DME supplemented 
with 10% FBS, 100 U/ml penicillin, 100 µg/ml streptomycin, 1× essential 
amino acids, and 1× nonessential amino acids. Rat UMR-106 osteoblast 
and H9c2 cardiomyoblast cell lines were obtained from the American Type 
Culture Collection. UMR-106 and MCF-7 cells were grown in MEM  me-
dium supplemented with 10% FBS, 100 U/ml penicillin, 100 µg/ml strepto-
mycin, and 0.25 µg/ml amphotericin B. H9c2 cells were grown in DME 
supplemented with 10% FBS, 100 U/ml penicillin, 100 µg/ml strepto-
mycin, and 0.25 µg/ml amphotericin B. Cells were grown in a humidified 
incubator in the presence of 5% CO2 at 37°C.
Adenovirus construction
Adenoviruses encoding GFP, RGS2, RGS4, and the RGS2 minigene were 
prepared according to the manufacturer’s protocol (Microbix Biosystems, 
Inc.). Adenoviral titers were determined using the AdEasy Viral Titer kit 
according to the manufacturer’s guidelines (Agilent Technologies).
Yeast two-hybrid assay
RGS2-binding partners were identified by screening against a mouse brain 
cDNA library using a yeast two-hybrid system (DupLEX-A; OriGene Tech-
nologies) according to the manufacturer’s protocol.
RGS protein purification
Histidine-tagged RGS1 and RGS4 proteins were expressed in Escherichia   
coli BL21 (DE3) strain and purified to >95% purity by nickel affinity chro-
matography followed by gel filtration chromatography using a 10/30 
column (Superdex 75 HR; GE Healthcare) as follows: 4 liters of bacterial 
culture were incubated with vigorous shaking at 37°C to an OD600 of 
0.55. Expression of the RGS proteins was induced by the addition of 1 mM 
isopropylthio--d-galactoside for 3 h before harvesting the bacteria by   
centrifugation. Bacteria were resuspended in 60 ml buffer A (50 mM Hepes, 
pH 8.0, 150 mM NaCl, 20 mM -mercaptoethanol, 0.1 mM PMSF, 10 µg/ml 
leupeptin, 1 µg/ml aprotinin, and 1% Triton X-100), lysozyme was added 
to a concentration of 0.2 mg/ml, and the suspension was mixed and incu-
bated on ice for 30 min. The suspension was incubated for an additional 
30 min on ice after the addition of 25 µg/ml DNase and 0.5 mM MgCl2. 
The mixture was centrifuged at 140,000 g for 30 min, and the volume of 
the supernatant was increased to 100 ml with buffer A supplemented with 
glycerol and imidazole (final concentrations of 20% and 20 mM, respec-
tively). A 50% slurry of 1.5 ml equilibrated nickel-nitrilotriacetic acid affin-
ity resin was added, and the mixture was incubated on a rocking platform 
for 1.5 h at 4°C, loaded onto a 30-ml column, washed with 30 ml of buffer 
A containing 0.5 M NaCl, and washed with 30 ml of buffer A without Triton 
X-100. Proteins were eluted with buffer A containing 200 mM imidazole. 
These protein samples were loaded and run through a 10/30 column 
(Superdex 75 HR) equilibrated with buffer B (50 mM Hepes, pH 8.0, 150 mM 
NaCl, 1 mM DTT, and 0.1 mM PMSF), and the peak fractions were col-
lected and stored at 80°C.
Histidine-tagged RGS2 and all its derivative mutants were purified 
from bacterial inclusion bodies as follows: 2 liters BL21 (DE3) bacterial 
culture was incubated with vigorous shaking at 37°C until mid-log phase. 
Induction was commenced by the addition of 1 mM isopropylthio--d-
galactoside for 3–4 h at 37°C. The bacteria were harvested by centrifuga-
tion, and pellets were stored at 80°C. Cells were thawed and resuspended 
in 30 ml of IB (inclusion body) buffer (20 mM Tris-HCl, pH 8.0, 10 mM EDTA, 
0.1 mM PMSF, 10 µg/ml leupeptin, 1 µg/ml aprotinin, and 1% Triton 
X-100), and 0.2 mg/ml lysozyme was added. The suspension was mixed 
and incubated at 30°C for 15 min followed by sonication on ice. Cell lysates 
were centrifuged at 15,000 g for 30 min at 4°C, and the pellet was JCB • VOLUME 186 • NUMBER 5 • 2009   764
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and eIF2B were purified from rat liver (Kimball et al., 1987), and the rate 
of exchange of [
3H]GDP bound to eIF2 for free, nonradioactively labeled 
GDP was measured in the absence and presence of the indicated purified 
RGS2 proteins. The activity of eIF2B was calculated as the slope of the 
nearest fit line with dpm as the dependent variable and time as the inde-
pendent variable.
Coimmunoprecipitation
For in vitro coimmunoprecipitations, 10
6 cells/ml Sf9 insect cells were in-
fected with recombinant baculovirus encoding Flag-tagged eIF2B subunit 
alone or coinfected with the three recombinant baculovirus stocks encod-
ing all five eIF2B subunits (Fabian et al., 1997). At 72 h after infection, 
cells were washed once with ice-cold PBS and lysed with immunoprecipita-
tion buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% Triton X-100, and 
10% glycerol). Cellular debris was removed by centrifugation at 14,000 g 
for 10 min at 4°C, and these lysates were mixed with 10 µg of RGS protein 
and subsequently precleared by mixing with protein G beads for 1 h at 
4°C and then centrifuged. The precleared lysate mixture was incubated 
with 2 µg anti-Flag M2 monoclonal antibody for 3h at 4°C. The protein G 
beads were washed three times with immunoprecipitation buffer and were 
resuspended in 2× Laemmli sample buffer.
For coimmunoprecipitation of endogenous proteins, confluent UMR-
106 cells in a T75 tissue culture flask were incubated for 3 h at 37°C with 
vehicle control or 100 µM forskolin to up-regulate RGS2 expression essen-
tially as described previously (Roy et al., 2006b). Cells were washed twice 
with ice-cold PBS and lysed by incubating with ice-cold hypotonic buffer 
(20 mM Hepes, pH 7.5, 50 mM KCl, 0.1 mM PMSF, 1 µg/ml aprotinin, 
10 µg/ml leupeptin, 0.1 mM EDTA, 10% [vol/vol] glycerol, and 1% Triton 
X-100) for 30 min. Cellular lysates were centrifuged at 10,000 g, and 
the supernatant was removed and precleared by rotating with 1 µg mouse 
IgG and 20 µl resuspended protein A/G PLUS-agarose for 30 min at 4°C. 
The precleared cellular extract (1 mg total cellular protein) was rotated with 
2 µg anti-eIF2B for 1 h at 4°C, and 25 µl protein A/G PLUS-agarose 
was subsequently added for an overnight incubation. Immunocomplexes 
were washed five times with PBS and resuspended in 2× Laemmli sam-
ple buffer.
Immunoblot analysis
Samples were placed in boiling water for 5 min and run on a 12% SDS poly-
acrylamide  gel,  transferred  to  a  polyvinylidene  fluoride  membrane,  and 
probed with the indicated antibodies according to the manufacturer’s recom-
mendations. Blots were visualized by chemiluminescence substrate (LumiGLO 
Reserve; Kirkegaard & Perry Laboratories, Inc.) using an imaging system 
(Fluorchem 8000; Alpha Innotech Corporation). Images were processed 
using Photoshop (CS2; Adobe) to adjust for brightness and contrast only.
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